Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4584531000168113 | inert substance diluent [1 x 3 mL syringe] (&) octreotide 20 mg modified release injection [1 x 20 mg vial], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4584541000168116 | octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack | has MPUU | inert substance diluent, 3 mL syringe | false | Inferred relationship | Some | 812132919 | |
| octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack | has MPUU | octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) | false | Inferred relationship | Some | 1093065997 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Octreotide Depot (Teva) (1 x 20 mg vial, 1 x 3 mL inert diluent syringe), 1 pack | Is a | False | octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR